Related references
Note: Only part of the references are listed.Alternative Splicing in Cancer and Immune Cells
Antoine Bernard et al.
CANCERS (2022)
Evidence for mitochondrial Lonp1 expression in the nucleus
Lara Gibellini et al.
SCIENTIFIC REPORTS (2022)
Alternative splicing in Alzheimer's disease
Giuseppe Biamonti et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2021)
A pipeline for multidimensional confocal analysis of mitochondrial morphology, function, and dynamics in pancreatic β-cells
Ahsen Chaudhry et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates
Silvia Belluti et al.
CELLS (2020)
Identification of an alternative splicing signature as an independent factor in colon cancer
Haitao Chen et al.
BMC CANCER (2020)
Mitochondrial spare respiratory capacity: Mechanisms, regulation, and significance in non-transformed and cancer cells
Philippe Marchetti et al.
FASEB JOURNAL (2020)
The role of microenvironment in tumor angiogenesis
Xianjie Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Akt phosphorylation of mitochondrial Lonp1 protease enables oxidative metabolism and advanced tumor traits
Jagadish C. Ghosh et al.
ONCOGENE (2019)
Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution
Jernej Ule et al.
MOLECULAR CELL (2019)
LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells
Lara Gibellini et al.
FRONTIERS IN ONCOLOGY (2018)
The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer
Ettaib El Marabti et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
Abnormalities in alternative splicing in diabetes: therapeutic targets
Zodwa Dlamini et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)
MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication
Shuhui Liu et al.
PLOS ONE (2017)
Lon protease: a novel mitochondrial matrix protein in the interconnection between drug-induced mitochondrial dysfunction and endoplasmic reticulum stress
Miriam Polo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Emerging role of Lon protease as a master regulator of mitochondrial functions
Marcello Pinti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2016)
The N-terminal domain plays a crucial role in the structure of a full-length human mitochondrial Lon protease
Sami Kereiche et al.
SCIENTIFIC REPORTS (2016)
Insulin receptor alternative splicing is regulated by insulin signaling and modulates beta cell survival
Pushkar Malakar et al.
SCIENTIFIC REPORTS (2016)
Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus
Lekh N. Dahal et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Hallmarks of alternative splicing in cancer
S. Oltean et al.
ONCOGENE (2014)
Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer
Yongzhang Liu et al.
ONCOTARGET (2014)
ATP-Dependent Lon Protease Controls Tumor Bioenergetics by Reprogramming Mitochondrial Activity
Pedro M. Quiros et al.
CELL REPORTS (2014)
Involvement of Endocytosis and Alternative Splicing in the Formation of the Pathological Process in the Early Stages of Parkinson's Disease
Anelya Kh. Alieva et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species
C-W Cheng et al.
CELL DEATH & DISEASE (2013)
The Alternative Heart: Impact of Alternative Splicing in Heart Disease
Enrique Lara-Pezzi et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2013)
The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives
Steven H. Bernstein et al.
BLOOD (2012)
RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing
Wei Guo et al.
NATURE MEDICINE (2012)
Identification of a Novel Human MD-2 Splice Variant That Negatively Regulates Lipopolysaccharide-Induced TLR4 Signaling
Pearl Gray et al.
JOURNAL OF IMMUNOLOGY (2010)
SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease
Lina A. Shehadeh et al.
PLOS ONE (2010)
Share Paper
